Filgotinib 200mg tablets
NHS hospitals in England used £40,573,928 of indicative cost of Filgotinib 200mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 33.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Filgotinib 200mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Filgotinib 200mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Lancashire Care Nhs Foundation Trust | £1,779,712 |
| King's College Hpl Nhs Foundation Trust | £1,453,460 |
| Royal Devon & Exeter Nhs Foundation Trst | £1,392,410 |
| Oxford University Hospitals Nhs Ft | £1,171,227 |
| Leeds Teaching Hpls Nhs Trust | £1,170,364 |
| University Hospital Southampton Nhs Ft | £1,132,387 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,080,601 |
| St George's Univ Hosps Foundation Nhst | £1,074,732 |
| Co.durham & Darlington Nhs Foundation Tr | £881,168 |
| Royal Free London Nhs Foundation Trust | £855,332 |
The primary-care picture
Filgotinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Filgotinib medicine page.